LW
Lisa Walter RBC Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
10
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
85.7%
Neutral
14.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $16 |
116%
upside
| 1 | -10% |
0
%
| 14 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $32 |
324%
upside
| 2 | -18% |
0
%
| 11 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $45 |
35%
upside
| 1 | +39% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $39 |
159%
upside
| 1 | +30% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $587 |
26%
upside
| 1 | +4.6% |
0
%
| 30 Oct ‘25 2 months ago |
|
|
|
Sector Perform
Maintained
| $4 | – | 1 | – |
–
| 28 Oct ‘25 2 months ago |
|